FDA Compounding Statements Beyond Judicial Review; Court Tosses Makena Suit

The agency’s public statements about compounded versions of the pre-term birth drug are exempt from judicial review under a 1985 Supreme Court decision, U.S. Judge Amy Berman Jackson said.